The "research use only" vial of injectable product was labelled as containing "retatrutide 10mg", an experimental weight loss medication
From shifting opinions on regulation to growing interest in alternatives, it's clear the conversation around GLP-1 medications is changing
Additionally, its only slated to be a temporary offering
When selecting a supplier, the most important factors are third-party testing (independent HPLC/MS analysis confirming purity at 98% or higher), domestic shipping from within Canada to avoid customs delays and potential seizures, and transparent documentation of product composition
Several companies are working on developing GLP-1 patches, but none of the versions currently sold online or in stores are FDA-approved
Benefits are also proportional to the amount of weight loss